412 related articles for article (PubMed ID: 2428045)
1. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
Zalman LS; Wood LM; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6975-9. PubMed ID: 2428045
[TBL] [Abstract][Full Text] [Related]
2. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
Zalman LS; Müller-Eberhard H
Mol Immunol; 1994 Mar; 31(4):301-5. PubMed ID: 8139583
[TBL] [Abstract][Full Text] [Related]
3. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
[TBL] [Abstract][Full Text] [Related]
4. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
Young JD; Jiang S; Liu CC; Hasselkus-Light CS
J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
[TBL] [Abstract][Full Text] [Related]
5. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
Schönermark S; Rauterberg EW; Shin ML; Löke S; Roelcke D; Hänsch GM
J Immunol; 1986 Mar; 136(5):1772-6. PubMed ID: 2419413
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
7. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
Rosenfeld SI; Jenkins DE; Leddy JP
J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
[TBL] [Abstract][Full Text] [Related]
8. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
9. The homologous restriction factor is immunologically related to complement components C8 and C9 and to lymphocyte pore-forming protein perforin through cysteine-rich domains.
Young JD; Rosse WF; Hasselkus-Light CS
Biochem Biophys Res Commun; 1990 Jan; 166(2):648-52. PubMed ID: 2302230
[TBL] [Abstract][Full Text] [Related]
10. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
Podack ER; Tschoop J; Müller-Eberhard HJ
J Exp Med; 1982 Jul; 156(1):268-82. PubMed ID: 6177822
[TBL] [Abstract][Full Text] [Related]
11. Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.
Zalman LS; Brothers MA; Müller-Eberhard HJ
J Immunol; 1989 Sep; 143(6):1943-7. PubMed ID: 2476489
[TBL] [Abstract][Full Text] [Related]
12. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
Sims PJ
Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
[TBL] [Abstract][Full Text] [Related]
13. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
14. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
Stewart JL; Monahan JB; Brickner A; Sodetz JM
Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.
Zalman LS; Wood LM; Frank MM; Müller-Eberhard HJ
J Exp Med; 1987 Feb; 165(2):572-7. PubMed ID: 2434597
[TBL] [Abstract][Full Text] [Related]
16. Restriction of cell lysis by homologous complement: I. An analysis of membrane attack complex formation on target membranes.
Houle JJ; Hoffmann EM; Esser AF
Blood; 1988 Feb; 71(2):280-6. PubMed ID: 3337896
[TBL] [Abstract][Full Text] [Related]
17. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
18. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
Ninomiya H; Sims PJ
J Biol Chem; 1992 Jul; 267(19):13675-80. PubMed ID: 1377690
[TBL] [Abstract][Full Text] [Related]
19. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
20. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
Hänsch GM; Hammer CH; Vanguri P; Shin ML
Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5118-21. PubMed ID: 6946459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
